WeVote
Log In

Bill

Bill

SB 2041

Uniform Controlled Dangerous Substances Act; modifying certain fee. Effective date.

2026 Regular Session Introduced by Lisa Standridge

SB 2041 adjusts fees in Oklahoma's controlled substances regulations, affecting drug licensing costs and state revenue with unspecified implementation impacts.

Second Reading referred to Public Safety
0
WeVote Research Nonpartisan
Bill Summary · SB 2041

Legislative bill overview

SB 2041 modifies Oklahoma's Uniform Controlled Dangerous Substances Act by adjusting certain fees associated with controlled substance regulations. The bill was introduced by Senator Lisa Standridge and includes a specified effective date for implementation. This appears to be a technical/administrative adjustment to existing drug control statutes rather than substantive policy reform.

Why is this important

Fee modifications within controlled substances legislation can affect licensing costs for pharmaceutical distributors, manufacturers, and regulated entities, potentially impacting healthcare access and compliance expenses. The specific fee changes, though not detailed in the action summary, may influence state revenue from drug-related licensing and the operational costs for businesses in regulated industries. This type of technical adjustment typically receives less public attention but can have meaningful economic consequences for regulated parties.

Potential points of contention

  • Lack of transparency in available information: The bill summary does not specify which fees are being modified or by how much, making it difficult to assess the full impact without reading the full text
  • Potential cost shifting: Depending on fee direction, changes could increase compliance burdens on pharmaceutical businesses, potentially raising drug prices or reducing market competition
  • Revenue implications: Fee increases generate state revenue but may be characterized as regressive regulation, while decreases may reduce funding for enforcement and oversight activities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.